Ever Fortune.AI Co., Ltd. (TPEX:6841)
Taiwan · Delayed Price · Currency is TWD 61.60
+0.20 (0.33%)
May 8, 2026, 1:30 PM CST
Ever Fortune.AI Revenue
In the year 2025, Ever Fortune.AI had annual revenue of 378.81M TWD with 12.23% growth. Ever Fortune.AI had revenue of 142.57M in the quarter ending December 31, 2025, with 34.33% growth.
Revenue
378.81M
Revenue Growth
+12.23%
P/S Ratio
15.36
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 378.81M | 41.29M | 12.23% |
| Dec 31, 2024 | 337.52M | 243.54M | 259.13% |
| Dec 31, 2023 | 93.98M | 40.08M | 74.35% |
| Dec 31, 2022 | 53.90M | 15.66M | 40.94% |
| Dec 31, 2021 | 38.24M | 34.76M | 996.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 20.51B |
| PharmaEssentia | 15.63B |
| Formosa Optical Technology | 4.13B |
| Sinphar Pharmaceutical | 3.37B |
| Pacific Hospital Supply | 2.38B |
| Orient Pharma | 1.40B |
| Savior Lifetec | 1.20B |
| Mycenax Biotech | 740.24M |